⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4556830 | 1.00 | — | — | |
| SCHEMBL4556846 | 0.97 | — | — | |
| SCHEMBL2081256 | 0.97 | — | — | |
| SCHEMBL4556501 | 0.97 | — | — | |
| SCHEMBL168922 | 0.97 | — | — | |
| SCHEMBL4557090 | 0.93 | — | — | |
| SCHEMBL409268 | 0.93 | — | — | |
| SCHEMBL414445 | 0.86 | — | — | |
| SCHEMBL4557221 | 0.77 | CXCR4 (0.33) | — | |
| SCHEMBL5508323 | 0.75 | KMT2A (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 403 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023217764-A1 | NOX INHIBITORS FOR USE IN THE TREATMENT OF ALPORT SYNDROME | CALLIDITAS THERAPEUTICS SUISSE SA (CH) | 2023-11-16 | — | — | WO | claimed |
| US-20210177811-A1 | USE OF NOX INHIBITORS FOR TREATMENT OF CANCER | CALLIDITAS THERAPEUTICS SUISSE SA (CH) | 2021-06-17 | — | — | US | claimed |
| EP-3703747-A1 | USE OF NOX INHIBITORS FOR TREATMENT OF CANCER | GenKyoTex Suisse SA (CH) | 2020-09-09 | — | — | EP | claimed |
| EP-3479843-A1 | USE OF NOX INHIBITORS FOR TREATMENT OF CANCER | GenKyoTex Suisse SA (CH) | 2019-05-08 | — | — | EP | claimed |
| CN-105121436-B | New pyridine derivate | 豪夫迈·罗氏有限公司 | 2018-07-27 | — | — | CN | claimed |
| CN-108026046-A | SUBSTITUTED QUINAZOLINE COMPOUNDS AND THEIR USE AS INHIBITORS OF G12C MUTANT KRAS, HRAS AND/OR NRAS PROTEINS | 亚瑞克西斯制药公司 | 2018-05-11 | — | — | CN | claimed |
| CN-105121436-A | Novel pyridine derivatives | HOFFMANN LA ROCHE | 2015-12-02 | — | — | CN | claimed |
| CN-105061422-A | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | GENKYOTEX S A | 2015-11-18 | — | — | CN | claimed |
| EP-2190291-B1 | HSP90 INHIBITORS WITH MODIFIED TOXICITY | UNIV COLORADO REGENTS (US) | 2015-10-14 | — | — | EP | claimed |
| US-9073919-B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | GENKYOTEX SA (CH) | 2015-07-07 | — | — | US | claimed |
| US-20020156080-A1 | Method for treating glaucoma IIIB | ALTEON, INC. | 2002-10-24 | — | — | US | claimed |
| WO-2002076975-A1 | CHEMICAL DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT | AVENTIS PHARMA S.A. (FR) | 2002-10-03 | — | — | WO | claimed |
| WO-2002053162-A1 | METHOD FOR TREATING GLAUCOMA IIIB | ALTEON, INC. (US) | 2002-07-11 | — | — | WO | claimed |
| EP-0790986-B1 | ANILINE DERIVATIVES | ZENECA LTD (GB) | 1999-01-20 | — | — | EP | claimed |
| EP-0773930-A1 | AROMATIC AMINO ETHERS AS PAIN RELIEVING AGENTS | ZENECA LIMITED (GB) | 1997-05-21 | — | — | EP | claimed |
| US-5321110-A | Thickeners for shampoo, hair conditioners | ISP INVESTMENTS INC. (US) | 1994-06-14 | — | — | US | claimed |
| WO-1993025595-A1 | CATIONIC POLYMER COMPOSITIONS | ISP INVESTMENTS INC. (US) | 1993-12-23 | — | — | WO | claimed |
| EP-0238883-B1 | OXABICYCLOHEPTANE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND USE | SUNTORY LIMITED (JP) | 1990-05-09 | — | — | EP | claimed |
| EP-0065823-A1 | Heterocyclic guanidines as histamine H-2 antagonists | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-12-01 | — | — | EP | claimed |
| US-3997534-A | PARASITICIDES, NEMATOCIDES | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-12-14 | — | — | US | claimed |